State Street’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

State Street’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-435,024	Closed	-$718K	–	5038
2022 Q1	$718K	Buy	435,024 +5,037	+1%	+$8.99K	﹤0.01%	3912
2021 Q4	$1.03M	Sell	429,987 -13,817	-3%	-$56.3K	﹤0.01%	3812
2021 Q3	$2.42M	Buy	443,804 +67,897	+18%	+$421K	﹤0.01%	3562
2021 Q2	$2.8M	Buy	375,907 +175,243	+87%	+$1.24M	﹤0.01%	3486
2021 Q1	$1.63M	Buy	200,664 +11,721	+6%	+$128K	﹤0.01%	3510
2020 Q4	$1.72M	Buy	188,943 +21,500	+13%	+$176K	﹤0.01%	3415
2020 Q3	$1.85M	Sell	167,443 -6,002	-3%	-$41.6K	﹤0.01%	3232
2020 Q2	$1.29M	Buy	173,445 +26,159	+18%	+$175K	﹤0.01%	3350
2020 Q1	$906K	Buy	147,286 +28,463	+24%	+$186K	﹤0.01%	3329
2019 Q4	$596K	Buy	118,823 +39,348	+50%	+$250K	﹤0.01%	3494
2019 Q3	$598K	Buy	79,475 +10,300	+15%	+$89.4K	﹤0.01%	3477
2019 Q2	$621K	Buy	+69,175	New	+$1.01M	﹤0.01%	3485

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street's KLDO Position: Q2 2022 in Review

State Street sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 435,024 shares — an estimated $718K sold.

State Street first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $2.8M in Q2 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

State Street reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
State Street sold 435,024 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $718K.
State Street first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
State Street's Kaleido Biosciences, Inc. Common Stock position peaked at $2.8M in Q2 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.